2015
DOI: 10.1089/omi.2015.0046
|View full text |Cite
|
Sign up to set email alerts
|

Novel Drug Targets for Food-Borne PathogenCampylobacter jejuni: An Integrated Subtractive Genomics and Comparative Metabolic Pathway Study

Abstract: Campylobacters are a major global health burden and a cause of food-borne diarrheal illness and economic loss worldwide. In developing countries, Campylobacter infections are frequent in children under age two and may be associated with mortality. In developed countries, they are a common cause of bacterial diarrhea in early adulthood. In the United States, antibiotic resistance against Campylobacter is notably increased from 13% in 1997 to nearly 25% in 2011. Novel drug targets are urgently needed but remain … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 61 publications
0
5
0
Order By: Relevance
“…Both quinic and shikimic organic acid exert an inhibitory effect on Staphylococcus aureus [ 76 ]; we detected some of their derivatives (3-dehydroquinic acid; 2,3-anhydro-quinic acid; 3-hydroxyimino quinic acid; 2-anhydro-3-fluoro-quinic acid; 3-dehydroshikimate) as AroQ binding ligands. Most of the AroE, AroQ, CheY, DapB, Ddl, LpxA, and PanD detected binding ligands were previously reported, in a similar in silico study, to bind to the same targets in Campylobacter jejuni [ 77 ].…”
Section: Discussionmentioning
confidence: 72%
“…Both quinic and shikimic organic acid exert an inhibitory effect on Staphylococcus aureus [ 76 ]; we detected some of their derivatives (3-dehydroquinic acid; 2,3-anhydro-quinic acid; 3-hydroxyimino quinic acid; 2-anhydro-3-fluoro-quinic acid; 3-dehydroshikimate) as AroQ binding ligands. Most of the AroE, AroQ, CheY, DapB, Ddl, LpxA, and PanD detected binding ligands were previously reported, in a similar in silico study, to bind to the same targets in Campylobacter jejuni [ 77 ].…”
Section: Discussionmentioning
confidence: 72%
“…Previous in silico studies have reported several potential drug targets through inclusive stepwise subtractive process of comparative genomic analysis of E. coli O157:H7 (a typical EHEC) and C. jejuni . 6,18,36…”
Section: Resultsmentioning
confidence: 99%
“…Previous in silico studies have reported several potential drug targets through inclusive stepwise subtractive process of comparative genomic analysis of E. coli O157:H7 (a typical EHEC) and C. jejuni. 6,18,36 About 60 antidiarrheal compounds were obtained from available literature ( Table 2). Twenty-one of these compounds were found to possess relevant functional characteristics based on the nature of targets that were predicted for 5 reference ligands used in this study, as well as reported function related to diarrheal and absence of cases of liver injury or other acute toxicity.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In developing countries, infections with Campylobacter are common in children under 2 years of age and found to be associated with increased incidence of diarrheal diseases as well as mortality [1,2]. In industrialized nations, Campylobacter is the cause of diarrhea during early years of adulthood [3]. Campylobacter infections are mostly acquired through consumption of contaminated water and food in resource-poor environment [4].…”
Section: Introductionmentioning
confidence: 99%